Shafa Orthopedic Journal

Published by: Kowsar

Antibiotic Prophylaxis in Periprosthetic Joint Infection (PJI): Literature Review and World Consensus (Part Six)

Javad Parvizi 1 , * , Mohammad Ghazavi 2 and Members of Pre-Op Antibiotics Committee of the Consensus Meeting 3
Authors Information
1 Rothman Institute, Thomas Jefferson University, Philadelphia, PA, USA
2 Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, IR Iran
3 William Arnold MD PhD; Katherine Belden MD; Goran Bicanic; Stefano Bini MD; Fabio Catani MD; Jiying Chen MD PhD; Mohammad Ghazavi MD FRCSC; Karine M Godefroy MD; Erik Hansen MD; Paul Holham MD; Hamid Hosseinzadeh MD; Kang II Kim MD; Klaus Kirketerp-Moller MD; Lars Lidgren MD PhD; Jian Hao Lin MD; Jess H Lonner MD; Christopher Moore MD; Panayiotis Papagelopoulos MD; Lazaros Poultsides MD MSc PhD; Khalid Saleh MD MSC FRCSC MHCM; Julia V Salmon MD, Edward Schwarz PhD; Randi Silibovsky MD (US); Jose Stuyck MD; Markus Vogt MD (International); Annette W Dahl MD; Koji Yamada MD.
Article information
  • Shafa Orthopedic Journal: May 31, 2016, 3 (2); e6165
  • Published Online: May 2, 2016
  • Article Type: Review Article
  • Received: March 29, 2016
  • Accepted: April 16, 2016
  • DOI: 10.17795/soj-6165

To Cite: Parvizi J, Ghazavi M, Committee of the Consensus Meeting M O P A. Antibiotic Prophylaxis in Periprosthetic Joint Infection (PJI): Literature Review and World Consensus (Part Six), Shafa Ortho J. 2016 ; 3(2):e6165. doi: 10.17795/soj-6165.

Copyright © 2016, Iran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Garey KW, Lai D, Dao-Tran TK, Gentry LO, Hwang LY, Davis BR. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother. 2008; 52(2): 446-51[DOI][PubMed]
  • 2. Spelman D, Harrington G, Russo P, Wesselingh S. Clinical, microbiological, and economic benefit of a change in antibiotic prophylaxis for cardiac surgery. Infect Control Hosp Epidemiol. 2002; 23(7): 402-4[DOI][PubMed]
  • 3. Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med. 2011; 171(1): 68-73[DOI][PubMed]
  • 4. Liu C. The bundled approach to MRSA surgical site infection prevention: is the whole greater than the sum of its parts?: comment on "Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery". Arch Intern Med. 2011; 171(1): 73-4[DOI][PubMed]
  • 5. Prokuski L. Prophylactic antibiotics in orthopaedic surgery. J Am Acad Orthop Surg. 2008; 16(5): 283-93[PubMed]
  • 6. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003; 24(5): 362-86[DOI][PubMed]
  • 7. Pofahl WE, Goettler CE, Ramsey KM, Cochran MK, Nobles DL, Rotondo MF. Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA. J Am Coll Surg. 2009; 208(5): 981-6[DOI][PubMed]
  • 8. Wirganowicz PZ, Eckardt JJ, Dorey FJ, Eilber FR, Kabo JM. Etiology and results of tumor endoprosthesis revision surgery in 64 patients. Clin Orthop Relat Res. 1999; (358): 64-74[PubMed]
  • 9. Safran MR, Kody MH, Namba RS, Larson KR, Kabo JM, Dorey FJ, et al. 151 endoprosthetic reconstructions for patients with primary tumors involving bone. Contemp Orthop. 1994; 29(1): 15-25[PubMed]
  • 10. Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Joint Surg Am. 1995; 77(8): 1154-65[PubMed]
  • 11. Capanna R, Morris HG, Campanacci D, Del Ben M, Campanacci M. Modular uncemented prosthetic reconstruction after resection of tumours of the distal femur. J Bone Joint Surg Br. 1994; 76(2): 178-86[PubMed]
  • 12. Mittermayer F, Krepler P, Dominkus M, Schwameis E, Sluga M, Heinzl H, et al. Long-term followup of uncemented tumor endoprostheses for the lower extremity. Clin Orthop Relat Res. 2001; (388): 167-77[PubMed]
  • 13. Ghert M, Deheshi B, Holt G, Randall RL, Ferguson P, Wunder J, et al. Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled study. BMJ Open. 2012; 2(6)[DOI][PubMed]
  • 14. Jansen B, Rinck M, Wolbring P, Strohmeier A, Jahns T. In vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated central venous catheter. J Biomater Appl. 1994; 9(1): 55-70[PubMed]
  • 15. Karchmer TB, Giannetta ET, Muto CA, Strain BA, Farr BM. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med. 2000; 160(21): 3294-8[PubMed]
  • 16. New implant technology: iodine-coating for infection control. 26th European Musculoskeletal Oncology Society Meeting.
  • 17. Tsuchiya H, Shirai T, Nishida H, Murakami H, Kabata T, Yamamoto N, et al. Innovative antimicrobial coating of titanium implants with iodine. J Orthop Sci. 2012; 17(5): 595-604[DOI][PubMed]
  • 18. Hardes J, von Eiff C, Streitbuerger A, Balke M, Budny T, Henrichs MP, et al. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol. 2010; 101(5): 389-95[DOI][PubMed]
  • 19. Gosheger G, Hardes J, Ahrens H, Streitburger A, Buerger H, Erren M, et al. Silver-coated megaendoprostheses in a rabbit model--an analysis of the infection rate and toxicological side effects. Biomaterials. 2004; 25(24): 5547-56[DOI][PubMed]
  • 20. Gosheger G, Goetze C, Hardes J, Joosten U, Winkelmann W, von Eiff C. The influence of the alloy of megaprostheses on infection rate. J Arthroplasty. 2008; 23(6): 916-20[DOI][PubMed]
  • 21. Buttaro MA, Gimenez MI, Greco G, Barcan L, Piccaluga F. High active local levels of vancomycin without nephrotoxicity released from impacted bone allografts in 20 revision hip arthroplasties. Acta Orthop. 2005; 76(3): 336-40[PubMed]
  • 22. Witso E, Persen L, Benum P, Aamodt A, Husby OS, Bergh K. High local concentrations without systemic adverse effects after impaction of netilmicin-impregnated bone. Acta Orthop Scand. 2004; 75(3): 339-46[DOI][PubMed]
  • 23. Buttaro MA, Pusso R, Piccaluga F. Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results. J Bone Joint Surg Br. 2005; 87(3): 314-9[PubMed]
  • 24. Michalak KA, Khoo PP, Yates PJ, Day RE, Wood DJ. Iontophoresed segmental allografts in revision arthroplasty for infection. J Bone Joint Surg Br. 2006; 88(11): 1430-7[DOI][PubMed]
  • 25. Khoo PP, Michalak KA, Yates PJ, Megson SM, Day RE, Wood DJ. Iontophoresis of antibiotics into segmental allografts. J Bone Joint Surg Br. 2006; 88(9): 1149-57[DOI][PubMed]
  • 26. Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg Br. 2008; 90(12): 1580-4[DOI][PubMed]
  • 27. Buttaro MA, Guala AJ, Comba F, Suarez F, Piccaluga F. Incidence of deep infection in aseptic revision THA using vancomycin-impregnated impacted bone allograft. Hip Int. 2010; 20(4): 535-41[PubMed]
  • 28. Witso E, Persen L, Loseth K, Bergh K. Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics. Acta Orthop Scand. 1999; 70(3): 298-304[PubMed]
  • 29. Buttaro MA, Gonzalez Della Valle AM, Pineiro L, Mocetti E, Morandi AA, Piccaluga F. Incorporation of vancomycin-supplemented bone incorporation of vancomycin-supplemented bone allografts: radiographical, histopathological and immunohistochemical study in pigs. Acta Orthop Scand. 2003; 74(5): 505-13[DOI][PubMed]
  • 30. Witso E, Persen L, Loseth K, Benum P, Bergh K. Cancellous bone as an antibiotic carrier. Acta Orthop Scand. 2000; 71(1): 80-4[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments